Skip to main content
SpringerLink
Log in

Rare Tumors in Children

  • Living reference work entry
  • First Online:
Pediatric Surgical Oncology

  • 42 Accesses

Abstract

It is difficult to define what is considered a “rare” tumor in children. The rarity can be relative, i.e., common in adults but the occurrence in children is rare (such as breast cancer or colorectal carcinoma). Rarity can also be an absolute term, defined by the number of cases per 100,000 or per million. Other opinions suggested that tumors are considered rare when there is no unified protocol of management. The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) defined a rare childhood cancer as one that has an incidence rate less than 2 per million per year, is not considered in clinical trials, or both.

This chapter discusses some of the rare tumors in children. This includes lung tumors such as inflammatory myofibroblastic pseudotumor, pulmonary hamartoma, pulmonary carcinoid tumor, and pulmonary metastatic tumors. It also includes cardiac tumors, Thymic neoplasms, and peripheral nerve sheath tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Murphy AJ, Lindsay Talbot AMD. Mediastinum, lung, and chest wall tumors. In: Losty PD, Quaglia ML, Sarnacki S, Jörg Fuchs TT, editors. Pediatric surgical oncology. 1st ed. Boca Raton: CRC Press; 2022. p. 97–112.

    Chapter  Google Scholar 

  2. Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg [Internet]. 2008;17(1):17–29. Available from: https://www.sciencedirect.com/science/article/pii/S1055858607000698

    Article  Google Scholar 

  3. Dishop MK, Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children’s hospital. Arch Pathol Lab Med. 2008;132(7):1079–103.

    Article  Google Scholar 

  4. Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Cin PD, Pinkus JL, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157(2):377–84.

    Article  CAS  Google Scholar 

  5. Hartman GE, Shochat SJ. Primary pulmonary neoplasms of childhood: a review. Ann Thorac Surg. 1983;36(1):108–19.

    Article  CAS  Google Scholar 

  6. Chan YF, White J, Brash H. Metachronous pulmonary and cerebral inflammatory pseudotumor in a child. Pediatr Pathol [Internet]. 1994;14(5):805–15. https://doi.org/10.3109/15513819409037678.

    Article  CAS  Google Scholar 

  7. Theilen T-M, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, et al. Crizotinib in ALK+ inflammatory myofibroblastic tumors – current experience and future perspectives. Pediatr Blood Cancer [Internet]. 2018;65(4):e26920. https://doi.org/10.1002/pbc.26920.

    Article  CAS  Google Scholar 

  8. McGinnis M, Jacobs G, El-Naggar A, Redline RW. Congenital peribronchial myofibroblastic tumor (so-called “congenital leiomyosarcoma”). A distinct neonatal lung lesion associated with nonimmune hydrops fetalis. Mod Pathol [Internet]. 1993;6(4):487–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8415597

    CAS  Google Scholar 

  9. Messinger YH, Stewart DR, Priest JR, Williams GM, Harris AK, Schultz KAP, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer [Internet]. 2015;121(2):276–85. https://doi.org/10.1002/cncr.29032.

    Article  Google Scholar 

  10. Smith NJ, Mukherjee D, Wang Y, Brazauskas R, Nelson AA, Cortina CS. Epidemiology and outcomes of primary pediatric lung malignancies: updates from the SEER database. Am J Surg [Internet]. 2021;222(4):861–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002961021000556

    Article  Google Scholar 

  11. Dehner LP, Messinger YH, Schultz KAP, Williams GM, Wikenheiser-Brokamp K, Hill DA. Pleuropulmonary blastoma: evolution of an entity as an entry into a familial tumor predisposition syndrome. Pediatr Dev Pathol [Internet]. 18(6):504–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26698637

  12. Bauer AJ, Stewart DR, Kamihara J, Harris AK, Turner J, Shah R, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies-response. Clin Cancer Res [Internet]. 2019;25(5):1689–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30824630

    Article  Google Scholar 

  13. Dehner LP, Schultz KA, Hill DA. Pleuropulmonary blastoma: more than a lung neoplasm of childhood. Mo Med [Internet]. 2019;116(3):206–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31527943 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6690274

  14. Feinberg A, Hall NJ, Williams GM, Schultz KAP, Miniati D, Hill DA, et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg [Internet]. 2016;51(1):33–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022346815006284

    Article  Google Scholar 

  15. Lichtenberger JP, Biko DM, Carter BW, Pavio MA, Huppmann AR, Chung EM. Primary lung tumors in children: radiologic-pathologic correlation. Radiographics. 2018;38(7):2151–72.

    Article  Google Scholar 

  16. Harting MT, Blakely ML. Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg [Internet]. 2006;15(1):25–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16458843

    Article  Google Scholar 

  17. Ahmed G, Zamzam M, Kamel A, Ahmed S, Salama A, Zaki I, et al. Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients. J Pediatr Surg [Internet]. 2019;54(4):775–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022346818303944

    Article  Google Scholar 

  18. Kayton ML, Huvos AG, Casher J, Abramson SJ, Rosen NS, Wexler LH, et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg [Internet]. 2006;41(1):200–6. Available from: https://www.sciencedirect.com/science/article/pii/S0022346805007669

    Article  Google Scholar 

  19. Fernandez-Pineda I, Daw NC, McCarville B, Emanus LJ, Rao BN, Davidoff AM, et al. Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience. J Pediatr Surg [Internet]. 2012;47(6):1250–4. Available from: https://www.sciencedirect.com/science/article/pii/S0022346812002734

    Article  Google Scholar 

  20. Karplus G, McCarville MB, Smeltzer MP, Spyridis G, Rao BN, Davidoff A, et al. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases? J Pediatr Surg [Internet]. 2009;44(4):665–71. Available from: https://www.sciencedirect.com/science/article/pii/S0022346808009172

    Article  Google Scholar 

  21. Su WT, Chewning J, Abramson S, Rosen N, Gholizadeh M, Healey J, et al. Surgical management and outcome of osteosarcoma patients with unilateral pulmonary metastases. J Pediatr Surg [Internet]. 2004;39(3):418–23. Available from: https://www.sciencedirect.com/science/article/pii/S0022346803008881

    Article  Google Scholar 

  22. Letourneau PA, Shackett B, Xiao L, Trent J, Tsao KJ, Lally K, et al. Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival. J Pediatr Surg [Internet]. 2011;46(2):332–5. Available from: https://www.sciencedirect.com/science/article/pii/S0022346810010006

    Article  Google Scholar 

  23. Rodeberg D, Arndt C, Breneman J, Lyden E, Donaldson S, Paidas C, et al. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. J Pediatr Surg [Internet]. 2005;40(1):256–62. Available from: https://www.sciencedirect.com/science/article/pii/S0022346804006487

    Article  Google Scholar 

  24. Meyers RL, Katzenstein HM, Krailo M, McGahren ED, Malogolowkin MH. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg [Internet]. 2007;42(12):2050–6. Available from: https://www.sciencedirect.com/science/article/pii/S0022346807005933

    Article  Google Scholar 

  25. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte J-B, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer [Internet]. 2002;94(4):1111–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11920482

    Article  Google Scholar 

  26. Kemp CD, Ripley RT, Mathur A, Steinberg SM, Nguyen DM, Fojo T, et al. Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute Experience. Ann Thorac Surg [Internet]. 2011;92(4):1195–200. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003497511011520

    Article  Google Scholar 

  27. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med [Internet]. 1993;117(10):1027–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8215825

    CAS  Google Scholar 

  28. Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM. Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J [Internet]. 1997;134(6):1107–14. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002870397700322

    Article  CAS  Google Scholar 

  29. Holley DG, Martin GR, Brenner JI, Fyfe DA, Huhta JC, Kleinman CS, et al. Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports. J Am Coll Cardiol [Internet]. 1995;26(2):516–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7608458

    Article  CAS  Google Scholar 

  30. Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV. Cardiac tumours in children. Orphanet J Rare Dis. 2007;2(1):1–14.

    Article  Google Scholar 

  31. Groves AM, Fagg NL, Cook AC, Allan LD. Cardiac tumours in intrauterine life. Arch Dis Child [Internet]. 1992;67(10 Spec No):1189–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1444556

  32. Harding CO, Pagon RA. Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma. Am J Med Genet [Internet]. 1990;37(4):443–6. https://doi.org/10.1002/ajmg.1320370402.

    Article  CAS  Google Scholar 

  33. Nir A, Tajik AJ, Freeman WK, Seward JB, Offord KP, Edwards WD, et al. Tuberous sclerosis and cardiac rhabdomyoma. Am J Cardiol [Internet]. 1995;76(5):419–21. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002914999801179

    Article  CAS  Google Scholar 

  34. Krymskaya VP. Tumour suppressors hamartin and tuberin: intracellular signalling. Cell Signal [Internet]. 2003;15(8):729–39. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0898656803000408

    Article  CAS  Google Scholar 

  35. Paladin D, Palmieri S, Russo MG, Pacileo G. Cardiac multiple rhabdomyomatosis: prenatal diagnosis and natural history. Ultrasound Obstet Gynecol [Internet]. 1996;7(1):84–5. https://doi.org/10.1046/j.1469-0705.1996.07010084.x.

    Article  Google Scholar 

  36. Takach TJ, Reul GJ, Ott DA, Cooley DA. Primary cardiac tumors in infants and children: immediate and long-term operative results. Ann Thorac Surg [Internet]. 1996;62(2):559–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8694623

    Article  CAS  Google Scholar 

  37. Isaacs H. Fetal and neonatal cardiac tumors. Pediatr Cardiol [Internet]. 2004;25(3):252–73. https://doi.org/10.1007/s00246-003-0590-4.

    Article  Google Scholar 

  38. Burke AP, Rosado-de-Christenson M, Templeton PA, Virmani R. Cardiac fibroma: clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg [Internet]. 1994;108(5):862–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7967668

    Article  CAS  Google Scholar 

  39. Kabbani SS, Jokhadar M, Meada R, Jamil H, Abdun F, Sandouk A, et al. Atrial myxoma: report of 24 operations using the biatrial approach. Ann Thorac Surg [Internet]. 1994;58(2):483–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/0003497594922349

    Article  CAS  Google Scholar 

  40. Malhotra V, Ferrans VJ, Virmani R. Infantile histiocytoid cardiomyopathy: three cases and literature review. Am Heart J [Internet]. 1994;128(5):1009–21. Available from: https://linkinghub.elsevier.com/retrieve/pii/0002870394906017

    Article  CAS  Google Scholar 

  41. Shapiro LM. Cardiac tumours: diagnosis and management. Heart [Internet]. 2001;85(2):218–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11156679

    Article  CAS  Google Scholar 

  42. Guleria P, Jain D. Thymic lesions of the paediatric age group: a comprehensive review of non-neoplastic and neoplastic etiologies. Mediastinum. 2019;3:24.

    Article  Google Scholar 

  43. Napieralska A, Miszczyk L. Thymic tumours in children. Pediatr Rep. 2022;14(1):1–7.

    Article  Google Scholar 

  44. Takeda S, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M, et al. Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol [Internet]. 2003;83(1):24–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12722093

    Article  Google Scholar 

  45. Wright CD. Management of thymomas. Crit Rev Oncol Hematol [Internet]. 2008;65(2):109–20. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1040842807000819

    Article  Google Scholar 

  46. Suster S, Moran CA. Thymic carcinoma: spectrum of differentiation and histologic types. Pathology [Internet]. 1998;30(2):111–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0031302516349145

    CAS  Google Scholar 

  47. Stachowicz-Stencel T, Orbach D, Brecht I, Schneider D, Bien E, Synakiewicz A, et al. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Eur J Cancer [Internet]. 2015;51(16):2444–52. https://doi.org/10.1016/j.ejca.2015.06.121.

    Article  Google Scholar 

  48. Liang X, Lovell MA, Capocelli KE, Albano EA, Birch S, Keating AK, et al. Thymoma in children: report of 2 cases and review of the literature. Pediatr Dev Pathol [Internet]. 13(3):202–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20055684

  49. Stachowicz-Stencel T, Synakiewicz A, Cornet M, Ferrari A, Garassino M, Masip JR, et al. Thymoma and thymic carcinoma in children and adolescents: the EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021;68(S4).

    Google Scholar 

  50. Saha S, Suhani S, Basak A, Agarwal N, Dewan P. Pediatric thymoma with a difference: report of a case and review of literature. J Surg Tech Case Rep [Internet]. 6(2):64–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25598946

  51. Ocal T, Türken A, Ciftçi AO, Senocak ME, Tanyel FC, Büyükpamukçu N. Thymic enlargement in childhood. Turk J Pediatr [Internet]. 42(4):298–303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11196746

  52. Okumura M, Shiono H, Minami M, Inoue M, Utsumi T, Kadota Y, et al. Clinical and pathological aspects of thymic epithelial tumors. Gen Thorac Cardiovasc Surg [Internet]. 2008;56(1):10–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18213465

    Article  Google Scholar 

  53. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol [Internet]. 2011;6(7):S1710–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1556086415328963

    Article  Google Scholar 

  54. Dadmanesh F, Sekihara T, Rosai J. Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am [Internet]. 2001;11(2):407–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11413764

    CAS  Google Scholar 

  55. Rod J, Orbach D, Verité C, Coze C, Stephan JL, Varlet F, et al. Surgical management of thymic epithelial tumors in children: lessons from the French Society of pediatric oncology and review of the literature. Pediatr Blood Cancer [Internet]. 2014;61(11):1910–5. https://doi.org/10.1002/pbc.25159.

    Article  CAS  Google Scholar 

  56. Ng VY, Scharschmidt TJ, Mayerson JL, Fisher JL. Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions. Anticancer Res [Internet]. 2013;33(6):2597–604. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23749914

    Google Scholar 

  57. LaFemina J, Qin L-X, Moraco NH, Antonescu CR, Fields RC, Crago AM, et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol [Internet]. 2013;20(1):66–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22878618

    Article  Google Scholar 

  58. Ferrari A, Bisogno G, Carli M. Management of childhood malignant peripheral nerve sheath tumor. Paediatr Drugs [Internet]. 2007;9(4):239–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17705563

    Article  Google Scholar 

  59. Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1 – a consensus overview. Hum Pathol [Internet]. 2017;67:1–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0046817717301673

    Article  CAS  Google Scholar 

  60. Hulsebos TJM, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosi. Am J Hum Genet [Internet]. 2007;80(4):805–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17357086

    Article  CAS  Google Scholar 

  61. Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S, et al. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol. 2021;141(1):101–16.

    Article  CAS  Google Scholar 

  62. Lim IIP, Rodeberg D, Dasgupta R. Non-rhabmyosarcoma soft tissue tumors. In: Pediatric surgical oncology [Internet]. Boca Raton: CRC Press; 2022. p. 216–24. https://doi.org/10.1201/9781351166126-23.

  63. Ahn D, Lee GJ, Sohn JH, Jeong JY. Fine-needle aspiration cytology versus core-needle biopsy for the diagnosis of extracranial head and neck schwannoma. Head Neck [Internet]. 2018;40(12):2695–700. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30457183

    Article  Google Scholar 

  64. Martin E, Flucke UE, Coert JH, van Noesel MM. Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease. Childs Nerv Syst [Internet]. 2020;36(10):2453–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32494969

    Article  Google Scholar 

  65. Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, et al. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors. Clin Cancer Res [Internet]. 2013;19(2):450–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23209032

    Article  CAS  Google Scholar 

  66. Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, et al. Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer [Internet]. 2016;56:77–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26824706

    Article  CAS  Google Scholar 

  67. Alaggio R, Turrini R, Boldrin D, Merlo A, Gambini C, Ferrari A, et al. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS One [Internet]. 2013;8(11):e80456. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24303016

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paediatric Surgery and Urology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

    Ibrahim A. Mostafa

Authors
  1. Ibrahim A. Mostafa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ibrahim A. Mostafa .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Kokila Lakhoo

  2. St. Jude Children's Research Hospital, Memphis, TN, USA

    Abdelhafeez H. Abdelhafeez

  3. Federal University of Sao Paulo, Sao Paulo, Brazil

    Simone Abib

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Crown

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Mostafa, I.A. (2023). Rare Tumors in Children. In: Lakhoo, K., Abdelhafeez, A.H., Abib, S. (eds) Pediatric Surgical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-71113-9_120-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-71113-9_120-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-71113-9

  • Online ISBN: 978-3-030-71113-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation